| Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease MV Barone, A Gimigliano, G Castoria, G Paolella, F Maurano, F Paparo, ... Gut 56 (4), 480-488, 2007 | 134 | 2007 |
| The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy F Perrone, C Jommi, M Di Maio, A Gimigliano, C Gridelli, S Pignata, ... Annals of oncology 27 (12), 2224-2229, 2016 | 130 | 2016 |
| Proteomic Profile Identifies Dysregulated Pathways in Cornelia de Lange Syndrome Cells with Distinct Mutations in SMC1A and SMC3 Genes A Gimigliano, L Mannini, L Bianchi, M Puglia, MA Deardorff, S Menga, ... Journal of Proteome Research 11 (12), 6111-6123, 2012 | 46 | 2012 |
| Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep‐2 cancer cells L Bianchi, F Bruzzese, A Leone, A Gagliardi, M Puglia, E Di Gennaro, ... Proteomics 11 (18), 3725-3742, 2011 | 24 | 2011 |
| Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach L Bianchi, A Gagliardi, R Gioia, R Besio, C Tani, C Landi, M Cipriano, ... Journal of proteomics 75 (15), 4717-4733, 2012 | 22 | 2012 |
| Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public … S Riva, L Arenare, M Di Maio, F Efficace, V Montesarchio, L Frontini, ... BMJ open 11 (10), e049128, 2021 | 19 | 2021 |
| A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system S Riva, F Efficace, M Di Maio, J Bryce, L Del Campo, F De Lorenzo, ... Supportive Care in Cancer 29, 3219-3233, 2021 | 14 | 2021 |
| Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label … S Pignata, G Scambia, C Schettino, L Arenare, C Pisano, D Lombardi, ... The Lancet Oncology 24 (3), 286-296, 2023 | 10 | 2023 |
| Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project … J Bryce, S Riva, M Di Maio, F Efficace, L Frontini, C Gallo, D Giannarelli, ... Journal of Clinical Oncology 37 (27_suppl), 91-91, 2019 | 5 | 2019 |
| R&D management in the pharma industry: The strategic role of CROs R Parente, R Feola, V Cucino, A Gimigliano Sinergie, 37-52, 2016 | 5 | 2016 |
| To be or not to be translational A Anastasio, A Armenante, A Gimigliano, A Moscarino, S Panzera, ... Translational Medicine@ Unisa 5, 5, 2013 | 5 | 2013 |
| Evaluation of SCO1 deletion on Saccharomyces cerevisiae metabolism through a proteomic approach T Gamberi, M Puglia, L Bianchi, A Gimigliano, C Landi, F Magherini, ... Proteomics 12 (11), 1767-1780, 2012 | 4 | 2012 |
| The strategic role of CRO in the R&D of life science industry R Parente, A Gimigliano, L Fontana, V Cucino R&D Management Conference, 2015 | 3 | 2015 |
| Measuring financial toxicity of cancer in the Italian health care system: Initial results of the patient reported outcome for fighting financial toxicity of cancer project … S Riva, M Di Maio, F Efficace, L Frontini, C Gallo, D Giannarelli, ... Annals of oncology 30, v681, 2019 | 2 | 2019 |
| The effect of financial difficulties on clinical outcomes in Italian cancer patients: A pooled analysis of 16 academic prospective clinical trials F Perrone, C Jommi, M Di Maio, A Gimigliano, C Gridelli, S Pignata, ... Annals of Oncology 27, iv111, 2016 | 2 | 2016 |
| Innovazione tecnologica e sviluppo di nuovi settori industriali: il settore delle Contract Research Organizations in Italia R Parente, L Fontana, A Gimigliano L'industria 36 (4), 511-534, 2015 | 1 | 2015 |
| 593P Longitudinal description of clinical trials for the development of cyclin-dependent kinases inhibitors C Cardone, C Schettino, P Gargiulo, L Arenare, S Bevilacqua, ... Annals of Oncology 31, S497-S498, 2020 | | 2020 |
| health economics The effect of financial difficulties on clinical outcomes in Italian cancer patients: A pooled analysis of 16 academic prospective clinical trials F Perrone, C Jommi, M Di Maio, A Gimigliano, C Gridelli, S Pignata, ... Annals of Oncology 27, vi572, 2016 | | 2016 |
| Technology Innovation and New Industry Development: The CRO Industry in Italy P Roberto, F Luciana, G Anna L'industria, 511-534, 2015 | | 2015 |
| Structural change in Industry as entrepreneurial opportunity: the rise of CRO in Life Science R Parente, G Anna, F Luciana Proceedings of 59th Annual International Council for Small Business …, 2014 | | 2014 |
